Published in Virchows Arch B Cell Pathol Incl Mol Pathol on January 01, 1992
The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol (1993) 4.18
New antiserum against Ki-67 antigen suitable for double immunostaining of paraffin wax sections. J Clin Pathol (1993) 1.20
Epitope analysis of antibodies recognising the cell proliferation associated nuclear antigen previously defined by the antibody Ki-67 (Ki-67 protein). J Clin Pathol (1994) 1.18
The Health Belief Model: a decade later. Health Educ Q (1984) 25.48
A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood (1994) 21.00
Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol (1984) 17.76
The Ki-67 protein: from the known and the unknown. J Cell Physiol (2000) 16.48
Social learning theory and the Health Belief Model. Health Educ Q (1988) 16.01
Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer (1983) 11.19
Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol (1993) 6.15
Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol (1992) 6.13
Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care (1975) 5.81
Understanding and improving patient compliance. Ann Intern Med (1984) 4.32
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology (2002) 4.22
The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol (1993) 4.18
Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol (1992) 4.04
CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood (2000) 3.99
Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol (1991) 3.82
The role of self-efficacy in achieving health behavior change. Health Educ Q (1986) 3.76
Drug prescribing and use in an American community. Ann Intern Med (1972) 3.55
Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin's lymphomas. J Histochem Cytochem (1980) 3.47
Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature (1982) 3.26
The normal and malignant germinal centre. Clin Haematol (1982) 3.19
Selected psychosocial models and correlates of individual health-related behaviors. Med Care (1977) 3.07
Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J Pathol (1992) 2.85
The Health Belief Model and prediction of dietary compliance: a field experiment. J Health Soc Behav (1977) 2.73
Myelodysplastic syndromes in childhood: report of 49 patients from a French multicentre study. French Society of Paediatric Haematology and Immunology. Br J Haematol (1996) 2.69
Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med (1997) 2.59
A field experiment to evaluate various outcomes of continuity of physician care. Am J Public Health (1974) 2.56
Identification of Hodgkin and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population. Int J Cancer (1982) 2.51
ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood (1998) 2.41
Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood (1990) 2.40
Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol Oncol (1985) 2.35
Human lymphoid cells express epithelial membrane antigen. Implications for diagnosis of human neoplasms. Lancet (1984) 2.25
Factors affecting diffusion of innovations among health professionals. Am J Public Health Nations Health (1970) 2.20
The emerging normal and disease-related roles of anaplastic lymphoma kinase. Cell Mol Life Sci (2004) 2.19
Strategies for enhancing patient compliance. J Community Health (1980) 2.17
New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest (1993) 2.10
The influence of client-provider relationships on teenage women's subsequent use of contraception. Am J Public Health (1985) 2.06
Differential education concerning therapeutics and resultant physician prescribing patterns. J Med Educ (1972) 2.00
Kisspeptin immunoreactive cells of the ovine preoptic area and arcuate nucleus co-express estrogen receptor alpha. Neurosci Lett (2006) 1.98
Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer (1987) 1.97
Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67. J Clin Pathol (1986) 1.97
A new approach to explaining sick-role behavior in low-income populations. Am J Public Health (1974) 1.88
Production of a monoclonal antibody reactive with human dendritic reticulum cells and its use in the immunohistological analysis of lymphoid tissue. J Clin Pathol (1983) 1.85
The relationship between physician characteristics and prescribing appropriateness. Med Care (1972) 1.83
Patient adherence to prescribed therapies. Med Care (1985) 1.82
A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation. Blood (1997) 1.82
The Ki-67 protein: fascinating forms and an unknown function. Exp Cell Res (2000) 1.81
Tumor necrosis factor enhances HLA-A,B,C and HLA-DR gene expression in human tumor cells. J Immunol (1987) 1.78
Human complement (C3b) receptors defined by a mouse monoclonal antibody. Immunology (1982) 1.78
BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood (1989) 1.76
Expression of the ALK tyrosine kinase gene in neuroblastoma. Am J Pathol (2000) 1.75
Kaposi's sarcoma-associated herpesvirus in non-AIDS related lymphomas occurring in body cavities. Am J Pathol (1996) 1.68
A revised European-American classification of lymphoid neoplasms proposed by the International Lymphoma Study Group. A summary version. Am J Clin Pathol (1995) 1.67
Hodgkin and Sternberg-Reed cells contain antigens specific to late cells of granulopoiesis. Int J Cancer (1982) 1.67
ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum. Am J Pathol (1998) 1.64
Using patients' descriptions of alcohol consumption, diet, medication compliance, and cigarette smoking: the validity of self-reports in research and practice. J Gen Intern Med (1989) 1.63
Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936. Leukemia (2006) 1.62
Compliance with a medical regimen for asthma: a test of the health belief model. Public Health Rep (1978) 1.61
PCR analysis of immunoglobulin heavy chain (IgH) and TcR-gamma chain gene rearrangements in the diagnosis of lymphoproliferative disorders: results of a study of 525 cases. Mod Pathol (2000) 1.60
TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations. Blood (1999) 1.59
Establishment of a novel anaplastic large-cell lymphoma-cell line (COST) from a 'small-cell variant' of ALCL. Leukemia (2004) 1.59
Predicting mothers' compliance with pediatric medical regimens. J Pediatr (1972) 1.59
Human dendritic reticulum cells of lymphoid follicles: their antigenic profile and their identification as multinucleated giant cells. Virchows Arch B Cell Pathol Incl Mol Pathol (1983) 1.58
Bringing the models together: an empirical approach to combining variables used to explain health actions. J Behav Med (1980) 1.56
Species-specific assessment of Mycobacterium leprae in skin biopsies by in situ hybridization and polymerase chain reaction. Lab Invest (1992) 1.55
A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation. Blood (1999) 1.54
Characteristics of Hodgkin's disease-derived cell lines. Cancer Treat Rep (1982) 1.51
The tyranny of health promotion. Public Health Rev (1986) 1.51
Hodgkin's disease: establishment and characterization of four in vitro cell lies. J Cancer Res Clin Oncol (1981) 1.50
New approach to assessing lung tumours in man. J Clin Pathol (1986) 1.50
AIDS and behavior change. Public Health Rev (1988) 1.48
Some influences on public participation in a genetic screening program. J Community Health (1975) 1.47
Evidence for the detection of the normal counterpart of Hodgkin and Sternberg-Reed cells. Hematol Oncol (1984) 1.47
The correlation of growth fractions with histologic grading and lymph node status in human mammary carcinoma. Cancer (1987) 1.44
Absence of Epstein-Barr virus nuclear antigen 2 in tumour cells of Hodgkin's disease. Lancet (1991) 1.44
Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur J Immunol (1994) 1.43
Production of monoclonal antibodies to human estrogen-receptor protein (ER) using recombinant ER (RER). Int J Cancer (1993) 1.42
T-cell rich B-cell lymphoma in the lung. Histopathology (1995) 1.40
Improper use of prescription drugs. Am Fam Physician (1990) 1.38
A continuous quality improvement approach to IL-372 documentation compliance in an academic emergency department, and its impact on dictation costs, billing practices, and average patient length of stay. Acad Emerg Med (2000) 1.38
Motivations as predictors of health behavior. Health Serv Rep (1972) 1.36
Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood (1999) 1.35